Courier Capital’s AbbVie ABBV Stock Holding History

Courier Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.99M	Buy	15,875 +27	+0.2%	+$5.81K	0.2%	116
2026 Q1	$3.45M	Buy	15,848 +731	+5%	+$162K	0.19%	115
2025 Q4	$3.45M	Sell	15,117 -110	-0.7%	-$25.1K	0.19%	113
2025 Q3	$3.53M	Hold	15,227	–	–	0.2%	110
2025 Q2	$2.83M	Buy	15,227 +85	+0.6%	+$15.8K	0.17%	121
2025 Q1	$3.17M	Buy	15,142 +130	+0.9%	+$25.3K	0.21%	113
2024 Q4	$2.67M	Buy	15,012 +219	+1%	+$40.3K	0.18%	112
2024 Q3	$2.92M	Sell	14,793 -1,813	-11%	-$338K	0.2%	105
2024 Q2	$2.85M	Sell	16,606 -1,113	-6%	-$184K	0.23%	88
2024 Q1	$3.23M	Sell	17,719 -1,215	-6%	-$209K	0.23%	92
2023 Q4	$2.93M	Hold	18,934	–	–	0.22%	99
2023 Q3	$2.82M	Sell	18,934 -1,677	-8%	-$246K	0.23%	95
2023 Q2	$2.78M	Buy	20,611 +1,370	+7%	+$201K	0.22%	99
2023 Q1	$3.07M	Sell	19,241 -218	-1%	-$33.3K	0.34%	62
2022 Q4	$3.14M	Sell	19,459 -338	-2%	-$51.8K	0.36%	63
2022 Q3	$2.66M	Sell	19,797 -20	-0.1%	-$2.87K	0.33%	71
2022 Q2	$3.04M	Sell	19,817 -585	-3%	-$89.4K	0.36%	66
2022 Q1	$3.31M	Sell	20,402 -1,440	-7%	-$209K	0.33%	69
2021 Q4	$2.96M	Sell	21,842 -1,309	-6%	-$155K	0.28%	82
2021 Q3	$2.5M	Sell	23,151 -18	-0.1%	-$2.06K	0.24%	89
2021 Q2	$2.61M	Buy	23,169 +116	+0.5%	+$13.1K	0.25%	88
2021 Q1	$2.5M	Buy	23,053 +1,442	+7%	+$154K	0.25%	87
2020 Q4	$2.32M	Buy	21,611 +289	+1%	+$27.8K	0.25%	85
2020 Q3	$1.98M	Buy	21,322 +374	+2%	+$35.2K	0.24%	90
2020 Q2	$2.07M	Buy	20,948 +1,867	+10%	+$164K	0.27%	81
2020 Q1	$1.53M	Sell	19,081 -699	-4%	-$59.5K	0.23%	86
2019 Q4	$1.78M	Buy	19,780 +951	+5%	+$79K	0.21%	90
2019 Q3	$1.39M	Buy	18,829 +21	+0.1%	+$1.44K	0.18%	98
2019 Q2	$1.37M	Buy	18,808 +69	+0.4%	+$5.42K	0.18%	104
2019 Q1	$1.51M	Buy	18,739 +952	+5%	+$77.9K	0.2%	97
2018 Q4	$1.64M	Sell	17,787 -194	-1%	-$17.1K	0.24%	89
2018 Q3	$1.7M	Sell	17,981 -3,979	-18%	-$377K	0.21%	96
2018 Q2	$2.04M	Buy	21,960 +50	+0.2%	+$4.88K	0.26%	89
2018 Q1	$2.07M	Sell	21,910 -729	-3%	-$80.1K	0.27%	83
2017 Q4	$2.19M	Sell	22,639 -149	-0.7%	-$14K	0.28%	81
2017 Q3	$2.02M	Hold	22,788	–	–	0.28%	80
2017 Q2	$1.65M	Sell	22,788 -299	-1%	-$20.1K	0.28%	72
2017 Q1	$1.5M	Sell	23,087 -513	-2%	-$32.3K	0.26%	74
2016 Q4	$1.48M	Sell	23,600 -1,177	-5%	-$71.8K	0.28%	73
2016 Q3	$1.56M	Sell	24,777 -1,125	-4%	-$72.8K	0.31%	69
2016 Q2	$1.6M	Hold	25,902	–	–	0.32%	68
2016 Q1	$1.48M	Buy	25,902 +116	+0.4%	+$6.46K	0.31%	71
2015 Q4	$1.53M	Sell	25,786 -1,160	-4%	-$66.8K	0.33%	70
2015 Q3	$1.47M	Sell	26,946 -750	-3%	-$48.8K	0.32%	72
2015 Q2	$1.86M	Sell	27,696 -1,439	-5%	-$93.9K	0.37%	64
2015 Q1	$1.71M	Sell	29,135 -1,180	-4%	-$71.3K	0.34%	69
2014 Q4	$1.98M	Sell	30,315 -661	-2%	-$41.7K	0.4%	60
2014 Q3	$1.79M	Sell	30,976 -1,348	-4%	-$74.8K	0.36%	68
2014 Q2	$1.82M	Buy	32,324 +1,035	+3%	+$54.3K	0.36%	69
2014 Q1	$1.61M	Hold	31,289	–	–	0.33%	75
2013 Q4	$1.65M	Sell	31,289 -720	-2%	-$35.4K	0.35%	70
2013 Q3	$1.43M	Buy	+32,009	New	+$1.42M	0.33%	70

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Courier Capital's ABBV Position: Q2 2026 in Review

Courier Capital increased its AbbVie (ABBV) stake by 0.17% in Q2 2026, buying an estimated $5.81K and bringing the position to 15,875 shares worth $3.99M. The position accounts for 0.2% of the portfolio, ranked #116.

Courier Capital first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. 2,093 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Courier Capital held 15,875 shares of AbbVie worth $3.99M as of Q2 2026.
Courier Capital bought 27 AbbVie shares in Q2 2026, an estimated $5.81K.
AbbVie made up 0.2% of Courier Capital's portfolio in Q2 2026, its #116 holding.
Courier Capital first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
2,093 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.